• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项随机临床试验对血糖受损者进行 6 年生活方式干预的长期效果对糖尿病相关微血管并发症的影响:中国大庆糖尿病预防结局研究。

Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.

机构信息

Department of Endocrinology, China-Japan Friendship Hospital, Yinghua Dong Lu, Chaoyang District, Beijing, 100029, China.

出版信息

Diabetologia. 2011 Feb;54(2):300-7. doi: 10.1007/s00125-010-1948-9. Epub 2010 Nov 3.

DOI:10.1007/s00125-010-1948-9
PMID:21046360
Abstract

AIMS/HYPOTHESIS: We determined the effects of 6 years of lifestyle intervention in persons with impaired glucose tolerance (IGT) on the development of retinopathy, nephropathy and neuropathy over a 20 year period.

METHODS

In 1986, 577 adults with IGT from 33 clinics in Da Qing, China were randomly assigned by clinic to a control group or one of three lifestyle intervention groups (diet, exercise, and diet plus exercise). Active intervention was carried out from 1986 to 1992. In 2006 we conducted a 20 year follow-up study of the original participants to compare the incidence of microvascular complications in the combined intervention group vs the control group.

RESULTS

Follow-up information was obtained on 542 (94%) of the 577 original participants. The cumulative incidence of severe retinopathy was 9.2% in the combined intervention group and 16.2% in the control group (p = 0.03, log-rank test). After adjusting for clinic and age, the incidence of severe retinopathy was 47% lower in the intervention group than the control group (hazard rate ratio 0.53, 95% CI 0.29-0.99, p = 0.048). No significant differences were found in the incidence of severe nephropathy (hazard rate ratio 1.05, 95% CI 0.16-7.05, intervention vs control, p = 0.96) or in the prevalence of neuropathy (8.6% vs 9.1%, p = 0.89) among the 20 year survivors.

CONCLUSIONS/INTERPRETATION: Lifestyle intervention for 6 years in IGT was associated with a 47% reduction in the incidence of severe, vision-threatening retinopathy over a 20 year interval, primarily due to the reduced incidence of diabetes in the intervention group. However, similar benefits were not seen for nephropathy or neuropathy.

摘要

目的/假设:我们旨在确定对糖耐量受损(IGT)患者进行 6 年的生活方式干预对 20 年内视网膜病变、肾病和神经病变发展的影响。

方法

1986 年,来自中国大庆 33 个诊所的 577 名 IGT 成年人按诊所被随机分配到对照组或三种生活方式干预组(饮食、运动和饮食加运动)之一。从 1986 年到 1992 年进行了积极的干预。2006 年,我们对原始参与者进行了 20 年的随访研究,以比较联合干预组与对照组的微血管并发症发生率。

结果

对 577 名原始参与者中的 542 名(94%)获得了随访信息。联合干预组严重视网膜病变的累积发病率为 9.2%,对照组为 16.2%(p=0.03,对数秩检验)。调整诊所和年龄后,干预组严重视网膜病变的发生率比对照组低 47%(风险比 0.53,95%CI 0.29-0.99,p=0.048)。在严重肾病(风险比 1.05,95%CI 0.16-7.05,干预与对照组,p=0.96)或 20 年幸存者中神经病(8.6%对 9.1%,p=0.89)的发生率方面未发现显著差异。

结论/解释:IGT 患者 6 年的生活方式干预与 20 年内严重威胁视力的视网膜病变发生率降低 47%相关,主要原因是干预组糖尿病发生率降低。然而,在肾病或神经病方面没有看到类似的益处。

相似文献

1
Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study.一项随机临床试验对血糖受损者进行 6 年生活方式干预的长期效果对糖尿病相关微血管并发症的影响:中国大庆糖尿病预防结局研究。
Diabetologia. 2011 Feb;54(2):300-7. doi: 10.1007/s00125-010-1948-9. Epub 2010 Nov 3.
2
Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study.生活方式干预对糖耐量受损人群的发病率和死亡率的影响:大庆糖尿病预防结局研究 30 年的结果。
Lancet Diabetes Endocrinol. 2019 Jun;7(6):452-461. doi: 10.1016/S2213-8587(19)30093-2. Epub 2019 Apr 26.
3
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.生活方式干预对糖耐量受损人群的心血管死亡率、全因死亡率和糖尿病发病率的影响:大庆糖尿病预防研究 23 年随访研究。
Lancet Diabetes Endocrinol. 2014 Jun;2(6):474-80. doi: 10.1016/S2213-8587(14)70057-9. Epub 2014 Apr 3.
4
Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study.糖耐量受损人群中,进展为糖尿病和恢复正常糖耐量与心血管和微血管疾病发展的相关性:大庆糖尿病预防结局研究 30 年随访的二次分析。
Diabetologia. 2021 Jun;64(6):1279-1287. doi: 10.1007/s00125-021-05401-x. Epub 2021 Feb 19.
5
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.中国大庆糖尿病预防研究中生活方式干预预防糖尿病的长期效果:一项20年随访研究
Lancet. 2008 May 24;371(9626):1783-9. doi: 10.1016/S0140-6736(08)60766-7.
6
[Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study].生活方式干预对糖尿病前期患者心血管疾病事件及死亡率降低的影响:大庆糖尿病预防研究的长期随访
Zhonghua Nei Ke Za Zhi. 2015 Jan;54(1):13-7.
7
Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.饮食和运动对糖耐量受损人群预防非胰岛素依赖型糖尿病的作用。大庆糖耐量受损和糖尿病研究。
Diabetes Care. 1997 Apr;20(4):537-44. doi: 10.2337/diacare.20.4.537.
8
Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.欧洲高血糖人群糖尿病微血管并发症的早期预防。ePREDICE 随机试验。研究方案、招募情况和部分基线数据。
PLoS One. 2020 Apr 13;15(4):e0231196. doi: 10.1371/journal.pone.0231196. eCollection 2020.
9
Influence of improvement or worsening of glucose tolerance on risk of stroke in persons with impaired glucose tolerance.糖耐量改善或恶化对糖调节受损者卒中风险的影响。
Int J Stroke. 2018 Dec;13(9):941-948. doi: 10.1177/1747493018784432. Epub 2018 Jun 29.
10
Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.诊断为葡萄糖耐量受损后非糖尿病状态与长期死亡和血管并发症风险的关系:大庆糖尿病预防结局研究的事后分析。
PLoS Med. 2024 Jul 9;21(7):e1004419. doi: 10.1371/journal.pmed.1004419. eCollection 2024 Jul.

引用本文的文献

1
Prediabetes.糖尿病前期
Nat Rev Dis Primers. 2025 Jul 17;11(1):49. doi: 10.1038/s41572-025-00635-0.
2
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association.《2025年韩国糖尿病管理临床实践指南:韩国糖尿病协会的建议》
Diabetes Metab J. 2025 Jul;49(4):582-783. doi: 10.4093/dmj.2025.0469. Epub 2025 Jul 1.
3
Impact of Lifestyle Interventions on the Progression of Diabetic Retinopathy in Patients Diagnosed With Diabetes Mellitus: A Systematic Review.生活方式干预对糖尿病患者糖尿病视网膜病变进展的影响:一项系统评价

本文引用的文献

1
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.糖尿病预防计划结果研究中糖尿病发病率和体重减轻的10年随访
Lancet. 2009 Nov 14;374(9702):1677-86. doi: 10.1016/S0140-6736(09)61457-4. Epub 2009 Oct 29.
2
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005.1950年至2005年弗雷明汉心脏研究中患糖尿病和未患糖尿病的男性与女性的全因死亡率和心血管疾病死亡率趋势
Circulation. 2009 Apr 7;119(13):1728-35. doi: 10.1161/CIRCULATIONAHA.108.829176. Epub 2009 Mar 23.
3
Changing course of diabetic nephropathy in the Pima Indians.
Cureus. 2025 Apr 17;17(4):e82411. doi: 10.7759/cureus.82411. eCollection 2025 Apr.
4
The Effect of Interventions to Prevent Type 2 Diabetes on the Development of Diabetic Retinopathy: The DPP/DPPOS Experience.预防2型糖尿病的干预措施对糖尿病视网膜病变发生发展的影响:糖尿病预防计划/糖尿病预防计划后续研究经验
Diabetes Care. 2022 Jul;45(7):1640-1646. doi: 10.2337/dc21-2417. Epub 2022 May 25.
5
The value of diabetes technology enabled coaching (DTEC) to support remission evaluation of medical interventions in T2D: Patient and health coach perspectives.糖尿病技术辅助指导(DTEC)对支持2型糖尿病医疗干预缓解评估的价值:患者和健康指导者的观点
PLOS Digit Health. 2025 Jan 9;4(1):e0000701. doi: 10.1371/journal.pdig.0000701. eCollection 2025 Jan.
6
Association between delay in diabetes development and mortality in people with obesity: Up to 33 years follow-up of the prospective Swedish Obese Subjects study.肥胖人群糖尿病发病延迟与死亡率之间的关联:对瑞典肥胖受试者前瞻性研究长达33年的随访
Diabetes Obes Metab. 2025 Jan;27(1):238-246. doi: 10.1111/dom.16010. Epub 2024 Oct 21.
7
Screening type 2 Diabetes mellitus among Indians using inflammatory biomarkers.使用炎症生物标志物筛查印度人群中的2型糖尿病
Bioinformation. 2024 May 31;20(5):515-519. doi: 10.6026/973206300200515. eCollection 2024.
8
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association.《2023年韩国糖尿病管理临床实践指南:韩国糖尿病协会完整版推荐》
Diabetes Metab J. 2024 Jul;48(4):546-708. doi: 10.4093/dmj.2024.0249. Epub 2024 Jul 26.
9
Non-diabetes status after diagnosis of impaired glucose tolerance and risk of long-term death and vascular complications: A post hoc analysis of the Da Qing Diabetes Prevention Outcome Study.诊断为葡萄糖耐量受损后非糖尿病状态与长期死亡和血管并发症风险的关系:大庆糖尿病预防结局研究的事后分析。
PLoS Med. 2024 Jul 9;21(7):e1004419. doi: 10.1371/journal.pmed.1004419. eCollection 2024 Jul.
10
Combined associations of visceral adipose tissue and adherence to a Mediterranean lifestyle with T2D and diabetic microvascular complications among individuals with prediabetes.糖尿病前期个体中内脏脂肪组织与坚持地中海式生活方式联合对2型糖尿病及糖尿病微血管并发症的影响
Cardiovasc Diabetol. 2024 Jun 12;23(1):201. doi: 10.1186/s12933-024-02284-1.
皮马印第安人糖尿病肾病病程的改变
Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1(Suppl 1):S10-4. doi: 10.1016/j.diabres.2008.09.014. Epub 2008 Oct 7.
4
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study.中国大庆糖尿病预防研究中生活方式干预预防糖尿病的长期效果:一项20年随访研究
Lancet. 2008 May 24;371(9626):1783-9. doi: 10.1016/S0140-6736(08)60766-7.
5
Mortality trends in men and women with diabetes, 1971 to 2000.1971年至2000年糖尿病男性和女性的死亡率趋势。
Ann Intern Med. 2007 Aug 7;147(3):149-55. doi: 10.7326/0003-4819-147-3-200708070-00167. Epub 2007 Jun 18.
6
The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program.糖尿病预防计划中糖耐量受损和新诊断糖尿病患者视网膜病变的患病率
Diabet Med. 2007 Feb;24(2):137-44. doi: 10.1111/j.1464-5491.2007.02043.x.
7
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.罗格列酮对糖耐量受损或空腹血糖受损患者糖尿病发生频率的影响:一项随机对照试验。
Lancet. 2006 Sep 23;368(9541):1096-105. doi: 10.1016/S0140-6736(06)69420-8.
8
The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).印度糖尿病预防计划表明,生活方式改变和二甲双胍可预防糖耐量受损的亚洲印度受试者患2型糖尿病(IDPP-1)。
Diabetologia. 2006 Feb;49(2):289-97. doi: 10.1007/s00125-005-0097-z. Epub 2006 Jan 4.
9
Predominant effect of kidney disease on mortality in Pima Indians with or without type 2 diabetes.肾脏疾病对患有或未患2型糖尿病的皮马印第安人死亡率的主要影响。
Kidney Int. 2005 Sep;68(3):1267-74. doi: 10.1111/j.1523-1755.2005.00523.x.
10
Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.生活方式干预预防2型糖尿病:一项针对IGT男性的日本试验。
Diabetes Res Clin Pract. 2005 Feb;67(2):152-62. doi: 10.1016/j.diabres.2004.06.010.